Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Hip Arthropathy, Knee Arthropathy, Vitamin D Deficiency
Interventions: Vitamin D3; Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hip Arthropathy
Interventions: Nerve Block, Periarticular Injection (PAI), Ropivacaine, Dex; Procedure · Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Osteoarthritis of Hip, Failure of Primary THA
Interventions: Bead placement during revision hip replacement surgery; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 25 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Labral Tear, Glenoid, Femoral Acetabular Impingement
Interventions: Blood Flow Restriction Rehabilitative Therapy, Sham BFR Rehabilitative Therapy; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Avascular Necrosis, Rheumatoid Arthritis
Interventions: POPOP (preoperative patient optimization program), SOC (standard of care); Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 80 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Osteoarthritis,Knee, Osteoarthritis Knees Both, Osteoarthritis Hip, Low Back Pain, Chronic Pain, Hip Pain Chronic, Knee Pain Chronic
Interventions: motivational enhancement and planning; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 50 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Osteoarthritis, Hip
Interventions: Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup.; Device
Lead sponsor: Medacta USA; Industry
Eligibility: Up to 75 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Oro Valley, Arizona • West Jordan, Utah • Spokane, Washington

Conditions: Hip Osteoarthritis, Avascular Necrosis of Hip
Interventions: Intraoperative Fluoroscopic Computer Navigation; Procedure
Lead sponsor: Southeast Orthopedic Specialists; Network
Eligibility: 18 Years to 95 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Anterior Knee Pain Syndrome, Patellofemoral Pain Syndrome
Interventions: Dry Needling, Soft Tissue Mobilization, Placebo Control, Hip and core strengthening exercises; Other
Lead sponsor: Mitchell Selhorst; Other
Eligibility: 13 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Fasinumab, Placebo; Drug · Other
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 21
States / cities: Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 15 more

Conditions: Osteoarthritis, Avascular Necrosis of Bone of Hip, Post-traumatic; Arthrosis, Congenital Hip Dysplasia
Interventions: Vivacit-E Liner; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 5
States / cities: Parker, Colorado • Chapel Hill, North Carolina • Charlotte, North Carolina + 2 more

Conditions: Osteoarthritis, Avascular Necrosis, Congenital Hip Dysplasia, Traumatic Arthritis
Interventions: C2a - Taper™ Acetabular System; Device
Lead sponsor: Biomet Orthopedics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 2
States / cities: Cedar Rapids, Iowa • Lexington, Kentucky

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Adapted-Engage-PA; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 65 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteoarthritis
Interventions: Cell injection; Procedure
Lead sponsor: Texas Plastic Surgery; Industry
Eligibility: 25 Years to 85 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Arthropathy of Knee Joint, Arthropathy of Hip Joint
Interventions: personalized prehabilitation; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 55 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis
Interventions: Encore CLP® Hip stem; Device
Lead sponsor: Encore Medical, L.P.; Industry
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Fresno, California

Conditions: Hip Osteoarthritis
Interventions: Surgery; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 206 participants
Timeline: 2017 – 2024
U.S. locations: 6
States / cities: Birmingham, Alabama • San Diego, California • Nashville, Tennessee + 3 more

Conditions: Non-inflammatory Degenerative Joint Disease
Interventions: ASR™-XL Modular Acetabular Cup System, Pinnacle™ acetabular shell; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 8
States / cities: Rancho Mirage, California • Cumming, Georgia • Morton Grove, Illinois + 5 more

Conditions: Hip-related Groin Pain, Femoroacetabular Impingement, Dysplasia Mild, Prearthritic Hip Disorder
Interventions: Movement Pattern Training, Manual Therapy; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 40 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteoarthritis, Chronic Pain
Interventions: ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release), Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 21 Years and older
Enrollment: 547 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 81
States / cities: Birmingham, Alabama • Mobile, Alabama • Peoria, Arizona + 69 more

Conditions: Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Pain, Arthralgia, Joint Pain
Interventions: JNJ-42160443, Placebo; Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 467 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 52
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 49 more

Conditions: Arthritis, Femoroacetabular Impingement, Osteochondritis Dissecans, Hip Fractures, Ankle Fractures, Tibial Fractures
Interventions: Decision tool, Standard treatment information; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 2,310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteoarthritis of the Hip
Interventions: Ropivacaine, Saline; Drug
Lead sponsor: The Christ Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hip and Knee Osteoarthritis
Interventions: Procedural, Bone Marrow concentrate injection; Other
Lead sponsor: Regenerative Pain Center, Illinois; Other
Eligibility: 18 Years to 85 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Des Plaines, Illinois

Search by objective public record fields.

Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications

Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty

Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis

Blood Flow Restriction Following Hip Arthroscopy

Impact of a POPOP on Preoperative Health, Eligibility, and Clinical & Patient-Reported Outcomes in TJA

Coach2Move: Physical Therapy to Improve Physical Activity in Individuals With Chronic MSK Conditions

Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component

THA With and Without Computer Navigation

Manual Therapy to Treat Gluteus Medius Trigger Points

Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee

Vivacit-E Post-market Follow-up Study

A Clinical Investigation of the C2a-Taper™ Acetabular System

Engaging African American Older Adults With Arthritis in a Physical Activity Intervention

Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints

A Personalized Prehabilitation Intervention In Elective Joint Replacement Surgery

Efficacy of the CLP® Hip - Retrospective

Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

Comparison of Movement Pattern Training and Manual Therapy for Prearthritic Hip Disorders

A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee

A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

Conjoint Analysis of Patient Preferences in Joint Interventions

Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty

Outcomes Data of Bone Marrow Stem Cells to Treat Hip and Knee Osteoarthritis